Qilu Pharmaceutical Co., Ltd.

This study is testing whether adding an experimental drug called QLS31905 to standard chemotherapy helps control advanced bile duct cancer that has a specific marker called CLDN18.2. Researchers will enroll 120 patients who haven't received prior treatment for their advanced canc…

This study is testing whether a new eye injection called QL1207H works as well as the established drug Eylea for treating wet age-related macular degeneration, a leading cause of vision loss in older adults. About 356 patients aged 50+ with active disease will receive injections …

This study is testing whether a new drug called QLC5508 works better than standard chemotherapy for people with advanced esophageal cancer that has continued to grow despite previous treatments. It will involve 466 adults whose cancer has spread and who have already tried platinu…

This study is testing if a new drug called QL2302 works as well and is as safe as an existing drug, Tezspire, for adults with severe asthma that isn't well-controlled by standard inhalers. About 636 participants will receive a monthly injection of one of the two drugs for a year,…

This study is testing a new combination of two investigational drugs, QLC5513 and QL1706, sometimes with standard chemotherapy, for people with advanced solid tumors that have spread. The main goals are to find the safest and most effective dose and to see how well the combinatio…

This study is testing an experimental drug called QLS5132, given by IV in combination with other cancer therapies, for people with advanced solid tumors like lung, stomach, ovarian, and endometrial cancer. The main goals are to find a safe and effective dose and to see how well t…

This study is testing whether a new capsule called QLS12010 can safely reduce disease activity in adults with moderate-to-severe rheumatoid arthritis. It will involve 180 participants who haven't gotten enough relief from at least two standard arthritis medications. People will b…

This study is testing whether QLS12010 capsules can help control moderate-to-severe hidradenitis suppurativa, a painful skin condition. The trial will involve 102 adults who haven't responded well to standard antibiotic treatments. Researchers will compare different doses against…

This study is testing whether a new oral medication called QLG1218 (daprodustat) works as well as the standard injected drug (darbepoetin alfa) for treating anemia in people with kidney failure who require dialysis. It will enroll 100 Chinese adults currently receiving dialysis a…

This is the first study in people testing a new cancer drug called QLS5308. Researchers want to find a safe dose and see if it helps control advanced solid tumors that have spread. The study will enroll about 192 people whose cancer has progressed despite standard treatments.

This study is testing whether QLS12010 capsules can safely reduce the severity of eczema and itching in adults with moderate-to-severe atopic dermatitis. About 160 participants will receive either the experimental capsules or a placebo for 16 weeks to compare results. The trial a…

This is the first human study of an experimental drug called QLH2405 for Alzheimer's disease. Researchers will test single injections in 68 healthy volunteers and people with early Alzheimer's or mild memory problems to check safety and how the body processes the drug. The study …

This study aims to see if a new drug called QL0911 is safe and effective at raising platelet counts in children with a chronic bleeding disorder called immune thrombocytopenia (ITP). It will involve 60 children aged 1 to 18 who have not responded well to previous treatments. The …

This study is testing several new combinations of experimental drugs for men with advanced prostate cancer that has spread. The first part aims to find safe doses, and the second part will see how well these combinations work to control the cancer. It is for men whose cancer has …

This study is testing whether adding an experimental drug called romiplostim N01 to standard immunosuppressive therapy works better than standard therapy alone for people newly diagnosed with severe aplastic anemia. It will involve 210 participants who have not yet received treat…

This study aims to see if a new drug called QL2107 behaves the same way in the body as the established cancer drug Keytruda. It will involve 122 adults with non-small cell lung cancer who have had their tumor surgically removed and completed chemotherapy. The main goal is to prov…

This is an early Phase 1 study to check the safety and basic effects of a new oral drug called QLS1410 for high blood pressure. It will enroll 78 healthy Chinese adults and people with mild hypertension to test different single and repeated doses. The main goal is to see how the …

This study is testing a new oral drug, QLC1401, when given alongside standard breast cancer medications. It aims to find a safe and effective dose for patients whose cancer has spread or is locally advanced. The main goals are to check for side effects and see if the combination …

This is the first study in humans testing a new cancer drug called QLS5316. Researchers will give the drug to 300 patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check if the drug is safe, determine the right dose, an…

This study is testing if a new injectable drug called QLC7401 can further lower 'bad' cholesterol in adults with an inherited form of high cholesterol. Participants, who are already on stable cholesterol medication, will receive either the new drug or a placebo injection. The mai…

This study is testing an experimental injectable drug called QLC7401 for people with high cholesterol that isn't well-controlled with their current medication. The main goal is to see if it safely lowers 'bad' LDL cholesterol more than a placebo injection. It will involve about 7…

This study is testing a new injectable drug called QLC7401 to see if it safely lowers 'bad' cholesterol (LDL-C) in adults. It will involve 510 people with high cholesterol who are not currently taking other cholesterol medications. Participants will receive either the real drug o…

This is the first study in people for a new drug called QLS2313, designed for patients with advanced blood cancers like lymphoma or leukemia that have come back or stopped responding to other treatments. The main goal is to find a safe and tolerable dose by giving the drug to sma…

This is a first-in-human study to check the safety and basic effects of a new drug called QLS7305 in healthy Chinese adults. Researchers will give different doses to 60 participants and closely monitor them for side effects, how the drug moves through the body, and its impact on …

This early-stage study aims to see how a new drug candidate, QL2302, compares to an existing drug, Tezspire, in healthy people. Researchers will measure how the body processes the drugs, check for safety issues, and see if they trigger an immune response. The goal is to gather in…

This is an early-stage study to see how a new drug called QL2109 compares to an existing drug, Darzalex, in healthy men. Researchers will measure how the body processes each drug and check for safety and immune reactions. The goal is to see if QL2109 behaves similarly to the appr…

This is the first human study of a new drug called QL2401, which is being developed for a serious liver condition called MASH. The study will test the safety and how the drug moves through the body in 70 healthy Chinese adults. Participants will receive either the drug or a place…

This study aims to understand how eating a high-fat meal affects how the body absorbs a new blood pressure medication called QLS1410. Twelve healthy Chinese adults will take the drug once with food and once on an empty stomach, with a week break in between. Researchers will measu…